International Journal of Molecular and Immuno Oncology

Most Viewed Articles

Total Downloads
1,936,449
Fulltext
1,263,045
PDF
673,404

Articles	Fulltext downloads	PDF downloads	Total downloads
Short Communication Driver mutations in oncogenesis Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_26_2020	37,036	4,411	41,447
Short Communication Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh Full text \| PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2020	37,777	3,293	41,070
Review Article Antibody-drug conjugate review in breast cancer: A targeted approach Full text \| PDF Year: 2024, Volume: 9, Issue: 3, September-December DOI: 10.25259/IJMIO_30_2024	9,043	22,781	31,824
Review Article Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2023	28,519	2,876	31,395
Review Article Genetic diversity and variation in chronic myeloid leukemia patients of Indian origin- Implications for treatment response and prognosis Full text \| PDF Year: 2024, Volume: 9, Issue: 3, September-December DOI: 10.25259/IJMIO_11_2024	8,771	21,396	30,167
Editorial Challenging conventional wisdom in molecular oncology: New perspectives Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2023	26,999	2,794	29,793
Original Article Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_15_2023	26,825	2,679	29,504
Case Report *Long-term efficacy of osimertinib in de novo* exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India** Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_16_2023	24,315	2,824	27,139
Review Article Molecular oncology and the role of artificial intelligence in advancing cancer treatment Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_17_2023	22,887	2,059	24,946
Review Article Emerging strategies in cancer immunotherapy: Expanding horizons and future perspectives Full text \| PDF Year: 2024, Volume: 9, Issue: 3, September-December DOI: 10.25259/IJMIO_24_2024	9,463	14,893	24,356
Editorial Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_2_2024	18,053	3,317	21,370
Review Article Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective article Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_3_2024	18,178	3,059	21,237
Case Report Case report – Muir–Torre syndrome – A skin-deep manifestation of underlying malignancy Full text \| PDF Year: 2024, Volume: 9, Issue: 3, September-December DOI: 10.25259/IJMIO_26_2024	8,585	12,503	21,088
Original Article Spectrum of lymphomas in India Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2023	18,491	2,436	20,927
News Editorial board tribute to Dr. Amit Verma Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December	16,353	3,439	19,792
Review Article High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_1_2024	16,863	2,769	19,632
Review Article Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_8_2022	13,894	5,487	19,381
Review Article Understanding immunotherapy and CAR-T-cells: A narrative review Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2023	16,856	2,409	19,265
Case Report Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_5_2022	12,965	6,224	19,189
Case Report Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2023	15,315	2,713	18,028
Cardio Oncology with ACOS Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_1_2022	12,556	4,877	17,433
Case Report Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_16_2021	14,547	2,727	17,274
Review Article Is continuous infusion of high-dose ifosfamide, a safe option? Drug review Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_21_2019	13,075	4,133	17,208
Review Article Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_29_2022	14,531	2,626	17,157
New Drug Update Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_13_2021	14,356	2,620	16,976
Review Article Combination of PARPi and anti-PD-L1 therapies in ovarian cancer Full text \| PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2022	14,941	1,784	16,725
Review Article Potential therapeutic molecular targets for better outcomes for patients with lung cancer Full text \| PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_27_2022	15,218	1,417	16,635
Review Article Immune dynamics of SARS-CoV-2 virus evolution Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_26_2021	11,268	5,051	16,319
Original Article Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change? Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_2_2022	11,641	4,672	16,313
Review Article Advances in immunotherapy for metastatic esophageal cancer Full text \| PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_14_2022	10,966	4,867	15,833
Case Series Dual driver in non-small cell lung carcinoma – therapeutic dilemma Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2021	12,599	2,781	15,380
Review Article Immuno-oncological era of breast cancer: A progressive path to better treatment Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_3_2022	9,615	5,745	15,360
Brief Commentary Breast cancer prognostic tools: A promising Indian option Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2020	10,153	5,059	15,212
Review Article Immuno-oncology of differentiated thyroid cancer Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_36_2020	11,153	3,901	15,054
Case Report L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_11_2023	13,047	1,935	14,982
Review Article The evolving role of precision medicine in the management of advanced sarcomas – A mini review Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2021	11,964	2,913	14,877
Review Article A compendium of population wide DNA methylation profile for oral cancer in India Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_2_2021	10,487	4,158	14,645
Review Article Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2021	11,417	3,141	14,558
Case Report Complete metabolic response with letrozole and palbociclib in advanced breast cancer Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_2_2019	8,975	5,510	14,485
Review Article The Cancer Genomic Atlas – “TO CONQUER CANCER” Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2020	10,451	3,916	14,367
Case Report Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_11_2022	11,192	3,025	14,217
Case Report Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2021	11,409	2,693	14,102
Editorial Nanobytes Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_7_2019	6,724	7,378	14,102
Review Article Molecular genetics changes in gallbladder carcinoma Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_19_2019	9,306	4,661	13,967
Brief Commentary ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_10_2021	10,859	3,007	13,866
Conference Review 6^th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2021	11,448	2,346	13,794
Erratum Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020) Full text \| PDF Year: 2021, Volume: 6, Issue: 2, October DOI: 10.25259/IJMIO_05_2020_ER	11,694	1,880	13,574
Brief Commentary Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_7_2021	10,474	3,068	13,542
Review Article Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_12_2022	8,255	5,127	13,382
Review Article Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology Full text \| PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2019	7,346	5,925	13,271

Most Viewed Articles

Driver mutations in oncogenesis

Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh

Antibody-drug conjugate review in breast cancer: A targeted approach

Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes

Genetic diversity and variation in chronic myeloid leukemia patients of Indian origin- Implications for treatment response and prognosis

Challenging conventional wisdom in molecular oncology: New perspectives

Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India

Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India

Molecular oncology and the role of artificial intelligence in advancing cancer treatment

Emerging strategies in cancer immunotherapy: Expanding horizons and future perspectives

Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer

Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective article

Case report – Muir–Torre syndrome – A skin-deep manifestation of underlying malignancy

Spectrum of lymphomas in India

Editorial board tribute to Dr. Amit Verma

High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective

Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching

Understanding immunotherapy and CAR-T-cells: A narrative review

Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia

Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph

Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival

Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male

Is continuous infusion of high-dose ifosfamide, a safe option? Drug review

Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets

Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor

Combination of PARPi and anti-PD-L1 therapies in ovarian cancer

Potential therapeutic molecular targets for better outcomes for patients with lung cancer

Immune dynamics of SARS-CoV-2 virus evolution

Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?

Advances in immunotherapy for metastatic esophageal cancer

Dual driver in non-small cell lung carcinoma – therapeutic dilemma

Immuno-oncological era of breast cancer: A progressive path to better treatment

Breast cancer prognostic tools: A promising Indian option

Immuno-oncology of differentiated thyroid cancer

L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report

The evolving role of precision medicine in the management of advanced sarcomas – A mini review

A compendium of population wide DNA methylation profile for oral cancer in India

Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective

Complete metabolic response with letrozole and palbociclib in advanced breast cancer

The Cancer Genomic Atlas – “TO CONQUER CANCER”

Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report

Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma

Nanobytes

Molecular genetics changes in gallbladder carcinoma

ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning

6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies

Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020)

Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management

Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications

Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology

**Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India**

6^th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies